OP Asset Management’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$21.2M Sell
42,228
-1,889
-4% -$907K 0.23% 73
2026
Q1
$21.7M Sell
44,117
-3,674
-8% -$1.99M 0.22% 67
2025
Q4
$27.7M Buy
47,791
+6,202
+15% +$3.51M 0.33% 52
2025
Q3
$20.2M Buy
41,589
+593
+1% +$276K 0.26% 66
2025
Q2
$16.6M Sell
40,996
-2,192
-5% -$916K 0.24% 74
2025
Q1
$21.5M Buy
+43,188
New +$23.4M 0.35% 44

Other funds holding TMO

OP Asset Management's TMO Position: Q2 2026 in Review

OP Asset Management reduced its Thermo Fisher Scientific (TMO) stake by 4.3% in Q2 2026, selling an estimated $907K and leaving 42,228 shares worth $21.2M. The position accounts for 0.23% of the portfolio, ranked #73.

OP Asset Management first reported a position in TMO in Q1 2025 and has held it in 6 quarters since. The position peaked at $27.7M in Q4 2025. 2,620 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • OP Asset Management held 42,228 shares of Thermo Fisher Scientific worth $21.2M as of Q2 2026.
  • OP Asset Management sold 1,889 Thermo Fisher Scientific shares in Q2 2026, an estimated $907K.
  • Thermo Fisher Scientific made up 0.23% of OP Asset Management's portfolio in Q2 2026, its #73 holding.
  • OP Asset Management first reported a position in Thermo Fisher Scientific in Q1 2025 and has held it in 6 quarters since.
  • OP Asset Management's Thermo Fisher Scientific position peaked at $27.7M in Q4 2025.
  • 2,620 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on OP Asset Management's 13F filing for Q2 2026, filed 28 Jul 2026.